Report to the Pharmaceutical Benefits Advisory Committee on the clinical and cost-effectiveness of the biological disease modifying anti-rheumatic drugs

Scuffham, PA, Whyte, P, Whitty, JA ORCID: https://orcid.org/0000-0002-5886-1933, Ng, S-K, Priest, V, Comans, T and Turkstra, E (2009) Report to the Pharmaceutical Benefits Advisory Committee on the clinical and cost-effectiveness of the biological disease modifying anti-rheumatic drugs. Griffith University.

Full text not available from this repository. (Request a copy)

Item Type:	Book
Faculty \ School:	Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups:	Faculty of Medicine and Health Sciences > Research Groups > Health Economics Faculty of Medicine and Health Sciences > Research Groups > Respiratory and Airways Group Faculty of Medicine and Health Sciences > Research Groups > Health Services and Primary Care Faculty of Medicine and Health Sciences > Research Groups > Public Health and Health Services Research (former - to 2023)
Depositing User:	Pure Connector
Date Deposited:	28 Apr 2016 11:00
Last Modified:	24 Sep 2024 08:38
URI:	https://ueaeprints.uea.ac.uk/id/eprint/58475
DOI:

Actions (login required)

View Item